Digga it's hard to answer that question because the company has said it won;t release quarterly number of implants sold because, as the numbers are still low, that would essentially give away their pricing information, and they still have variable pricing. This will change once reimbursements are more established.
Right now we know the $ sales per quarter and the total number of implants (200 reported last month).
Most implants right now are being funded by the company as part of 2 major studies. When they stop, if they are positive, more private sales are likely to occur. And hopefully the trials will lead to government reimbursement, rather than hospital based , philanthropic, private health insurance based, or privately funded reimbursement.
- Forums
- ASX - By Stock
- Ann: Significant Growth in Commercial Treatment Sales in Q4 FY24
Digga it's hard to answer that question because the company has...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $52.97M |
Open | High | Low | Value | Volume |
1.4¢ | 1.4¢ | 1.3¢ | $56.50K | 4.041M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 12011630 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 6141425 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 9458984 | 0.013 |
18 | 9551684 | 0.012 |
18 | 8704466 | 0.011 |
17 | 11298020 | 0.010 |
11 | 4321222 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 4941425 | 7 |
0.015 | 2383570 | 9 |
0.016 | 4392825 | 5 |
0.017 | 5155548 | 3 |
0.018 | 1632208 | 4 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
OSL (ASX) Chart |